Mid Cap Insider Trading Activity

Track insider buying and selling in mid cap stocks. See which executives are buying, net insider activity, and % of float traded across 2,257 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Economic Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Financials Mid (2.1bn) 0 No activity — 50%+
Consumer Cyclicals Mid (2.1bn) 0 No activity — 50%+
IN Jindal SAW Ltd (JINDALSAW)
Basic Materials Mid (2.1bn) 0 No activity — 50%+
Healthcare Mid (2.1bn) 0 No activity — 15–50%
US Buckle Inc (BKE)
Consumer Cyclicals Mid (2.1bn) 0 No activity — 15–50%
Consumer Cyclicals Mid (2.1bn) 1–5 $10M–$100M 0–15% 15–50%
Utilities Mid (2.1bn) 0 No activity — 0–15%
SG Karooooo Ltd (KARO)
Technology Mid (2.1bn) -1–5 -$10M–$100M -0–15% 50%+
Technology Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Consumer Non-Cyclicals Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Financials Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
US Xencor Inc (XNCR)
Healthcare Mid (2.1bn) 0 No activity — 0–15%
Industrials Mid (2.1bn) 0 No activity — 0–15%
Consumer Cyclicals Mid (2.1bn) 0 No activity — 0–15%
US Sunrun Inc (RUN)
Energy Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Basic Materials Mid (2.1bn) 0 No activity — 0–15%
Consumer Cyclicals Mid (2.1bn) 0 No activity — 0–15%
Financials Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Consumer Cyclicals Mid (2.1bn) 1–5 < $100K 0–15% 15–50%
Industrials Mid (2.1bn) 0 No activity — 0–15%
KR HANALL BIOPHARMA (009420)
- Mid (2.1bn) 0 No activity — 15–50%
Financials Mid (2.1bn) 0 No activity — 15–50%
Real Estate Mid (2.1bn) 0 No activity — 0–15%
Industrials Mid (2.0bn) -1–5 -$100K–$1M -0–15% 15–50%
Healthcare Mid (2.0bn) 0 No activity — 0–15%
US Cimpress PLC (CMPR)
Industrials Mid (2.0bn) -1–5 -$1M–$10M -0–15% 15–50%
Healthcare Mid (2.0bn) 0 No activity — 15–50%
Consumer Non-Cyclicals Mid (2.0bn) 0 No activity — 15–50%
Consumer Cyclicals Mid (2.0bn) 0 No activity — 0–15%
Healthcare Mid (2.0bn) 0 No activity — 0–15%
US Progyny Inc (PGNY)
Healthcare Mid (2.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Real Estate Mid (2.0bn) 6–10 -$100K–$1M -0–15% 0–15%
Industrials Mid (2.0bn) 0 No activity — 0–15%
Consumer Cyclicals Mid (2.0bn) 1–5 $100K–$1M 0–15% 0–15%
Energy Mid (2.0bn) 0 $100K–$1M 0–15% 0–15%
IN Sammaan Capital Ltd (SAMMAANCAP)
Financials Mid (2.0bn) 0 No activity — 0–15%
- Mid (2.0bn) 0 No activity — 15–50%
Financials Mid (2.0bn) 1–5 < $100K 0–15% 0–15%
Industrials Mid (2.0bn) 0 No activity — 0–15%
Healthcare Mid (2.0bn) 0 No activity — 0–15%
- Mid (2.0bn) 0 No activity — 0–15%
Technology Mid (2.0bn) 0 No activity — —
Financials Mid (2.0bn) 0 No activity — 15–50%
Consumer Cyclicals Mid (2.0bn) 0 No activity — 0–15%
FR Believe SAS (BLV)
Consumer Cyclicals Mid (2.0bn) 0 No activity — 50%+
Industrials Mid (2.0bn) 0 No activity — 0–15%
Industrials Mid (2.0bn) -1–5 -$1M–$10M -0–15% 15–50%
- Mid (2.0bn) 0 No activity — 15–50%
Financials Mid (2.0bn) 0 No activity — 0–15%
Financials Mid (2.0bn) 0 No activity — 50%+
KY Youdao Inc (DAO)
Technology Mid (2.0bn) 0 No activity — 0–15%
Utilities Mid (2.0bn) 0 No activity — 15–50%
IN Jubilant Pharmova Ltd (JUBLPHARMA)
Healthcare Mid (2.0bn) 0 No activity — 50%+
SE Elekta AB (publ) (EKTA-B)
Healthcare Mid (2.0bn) 1–5 $1M–$10M 0–15% 0–15%
Basic Materials Mid (2.0bn) 0 No activity — 15–50%
Financials Mid (2.0bn) 0 No activity — 0–15%
Financials Mid (2.0bn) 0 No activity — 0–15%